Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia-Reference-Cited by-同舟云学术

Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia

Published:2017-10-11 Issue:10 Volume:6 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Toth Peter P.¹²,Worthy Gillian³⁴,Gandra Shravanthi R.⁴,Sattar Naveed⁵,Bray Sarah⁴,Cheng Lung‐I.⁴,Bridges Ian⁴,Worth Gavin M.⁴,Dent Ricardo⁴,Forbes Carol A.³,Deshpande Sohan³,Ross Janine³,Kleijnen Jos³⁶,Stroes Erik S. G.⁷

Affiliation:

1. Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University and School of Medicine, Baltimore, MD

2. CGH Medical Center, Sterling, IL

3. Kleijnen Systematic Reviews Ltd, York, United Kingdom

4. Amgen Inc, Thousand Oaks, CA

5. University of Glasgow, United Kingdom

6. Department of Family Medicine, Maastricht University, Maastrict, The Netherlands

7. Faculty of Medicine, University of Amsterdam, The Netherlands

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference56 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

2. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

3. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

4. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

5. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review;Current Therapeutic Research;2024-09

2. Lipid profile and risk factors for neoatherosclerosis after drug-eluting stent implantation in acute coronary syndrome;Journal of Clinical Lipidology;2024-08

3. Impact of national drug price negotiation policy on the accessibility and utilization of PCSK9 inhibitors in China: an interrupted time series analysis;International Journal for Equity in Health;2024-06-05

4. Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings;Advances in Therapy;2024-04-30

5. Atherosclerotic cardiovascular disease landscape in Singapore;Frontiers in Cardiovascular Medicine;2024-04-24